drugset / Trial / NCT05320926

Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

NCT05320926

Recruiting 3744 enrolled Yonsei University
RandomizedParallel-groupOpen-labelTreatment

Summary

Previous randomized clinical trials have deomonstrated the efficacy and safety of short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), however, the single antiplatelet agent to be maintained after short-term DAPT was different. Therefore, which antiplatelet agent to be maintained after short-term DAPT needs further invstigations.

Timeline

Start
2022-07-26
Primary completion
2028-07-10
Completion
2028-07-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule
Subject Clopidogrel Small molecule

Indications